Eurofarma Laboratorios S.a.
Clinical trials sponsored by Eurofarma Laboratorios S.a., explained in plain language.
-
New pill could regrow hair in balding men
Disease control Not yet recruitingThis study tests whether a daily oral minoxidil pill (N1087) can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks, with the dose slowly increased. The main goal is to see if…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hair loss drug for women enters final testing phase
Disease control Not yet recruitingThis Phase 3 trial tests whether an oral solution called N1087 can help women with female pattern hair loss regrow hair. About 372 women aged 18 to 60 will receive either N1087 or a placebo daily for 24 weeks. The study measures changes in hair density and thickness using scalp p…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New asthma inhaler faces off against standard treatment in major trial
Disease control Not yet recruitingThis Phase 3 trial tests a new inhaler called N0783 against a standard asthma inhaler (Alenia) in 174 adults with moderate asthma. The goal is to see if the new drug works just as well at improving lung function and controlling symptoms. Participants will be randomly assigned to …
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC